This reversal holds particular relevance to translating a small molecule p75NTR ligand to the clinic, wherein AD patients, even at early clinical stages, would more likely be in pathologically advanced stages of disease prior to treatment. The gene discussed is NGFR; the disease is Alzheimer disease.